Health and Fitness Health and Fitness
Tue, August 7, 2012
Mon, August 6, 2012
Fri, August 3, 2012
Thu, August 2, 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
00 p.m. EDT
Wed, August 1, 2012
[ Wed, Aug 01st 2012 ] - Market Wire
Head of European Operations
Tue, July 31, 2012
Mon, July 30, 2012
Sun, July 29, 2012
Fri, July 27, 2012
Thu, July 26, 2012
Wed, July 25, 2012
Tue, July 24, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Neogen reports year end results
Mon, July 23, 2012
Sun, July 22, 2012
Sat, July 21, 2012
Fri, July 20, 2012
Thu, July 19, 2012
Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012

MELA Sciences to Release Second Quarter Financial Results and Host Conference Call on Tuesday, August 7, 2012


//health-fitness.news-articles.net/content/2012/ .. st-conference-call-on-tuesday-august-7-2012.html
Published in Health and Fitness on Wednesday, July 25th 2012 at 7:46 GMT by Market Wire   Print publication without navigation


July 25, 2012 10:21 ET

MELA Sciences to Release Second Quarter Financial Results and Host Conference Call on Tuesday, August 7, 2012

IRVINGTON, NY--(Marketwire - Jul 25, 2012) - [ MELA Sciences, Inc. ] (NASDAQ: [ MELA ]), the medical device company that has developed and is commercializing [ MelaFind ]®, today announced that it will release its 2012 second quarter financial results after the close of trading on Tuesday, August 7, 2012. MELA Sciences executives will also host a conference call that day at 4:30 PM ET to discuss the results as well as provide a general business update.

Date: Tuesday, August 7, 2012
Time: 4:30 PM ET

To participate in the teleconference, please dial:
Domestic toll-free: (888) 240 9345
International: (913) 312 1513
Participant Code: 4218253

To listen via live webcast, please go to the investor relations section of the MELA Sciences website at [ http://www.melasciences.com ] approximately 10 minutes prior to the teleconference start time. If you are unable to participate during the live conference call and webcast, the conference call audio cast will be archived and available for replay for approximately 90 days.

About MELA Sciences, Inc.
MELA Sciences is a medical device company focused on the commercialization of its flagship product, MelaFind®, and its further design and development. MelaFind is a non-invasive tool to provide additional information to dermatologists during melanoma skin examinations. The device uses light from visible to near-infrared wavelengths to evaluate skin lesions up to 2.5 mm beneath the skin. The device provides information on a lesion's level of morphologic disorganization to provide additional objective information that may be used by dermatologists in the biopsy decision-making process. MelaFind has been approved by the US Food and Drug Administration for use in the US. In addition, MelaFind has received CE Mark approval and is approved for use in the European Union.

For more information on MELA Sciences, visit [ www.melasciences.com ].



Publication Contributing Sources